An exploratory analysis of the ability of a cefepime trough concentration greater than 22 mg/L to predict neurotoxicity-Reference-Cited by-同舟云学术

An exploratory analysis of the ability of a cefepime trough concentration greater than 22 mg/L to predict neurotoxicity

Published:2016-02 Issue:2 Volume:22 Page:78-83
ISSN:1341-321X
Container-title:Journal of Infection and Chemotherapy
language:en
Short-container-title:Journal of Infection and Chemotherapy

Author:

Rhodes Nathaniel J.,Kuti Joseph L.,Nicolau David P.,Neely Michael N.,Nicasio Anthony M.,Scheetz Marc H.^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Reference10 articles.

1. FDA drug safety communication: cefepime and risk of seizure in patients not receiving dosage adjustments for kidney impairment;U.S. Food and Drug Administration,2012

2. The neurotoxicity and safety of treatment with cefepime in patients with renal failure;Sonck;Nephrol Dial Transpl,2008

3. Daptomycin exposure and the probability of elevations in the creatine phosphokinase level: data from a randomized trial of patients with bacteremia and endocarditis;Bhavnani;Clin Infect Dis,2010

4. High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function;Lamoth;Antimicrob Agents Chemother,2010

5. Population pharmacokinetics of high-dose, prolonged-infusion cefepime in adult critically ill patients with ventilator-associated pneumonia;Nicasio;Antimicrob Agents Chemother,2009

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case Report: Cefepime Induced Neurotoxicity Following a Change in Infusion Time;Hospital Pharmacy;2024-03-07

2. Cefepime-induced neurotoxicity in non-critically ill medical patients: a retrospective cohort study;Signa Vitae;2024

3. Delayed Diagnosis of an Invisible Seizure: Cefepime-Induced Non-convulsive Status Epilepticus;Cureus;2023-10-10

4. Beta-Lactam Dose Optimisation in the Intensive Care Unit: Targets, Therapeutic Drug Monitoring and Toxicity;Antibiotics;2023-05-08

5. Use of therapeutic drug monitoring to characterize cefepime‐related neurotoxicity;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2022-12-02